Enhancement of bone-bonding ability of bioactive titanium by prostaglandin E2 receptor selective agonist

Biomaterials

Volumn 29, Issue 7, 2008, Pages 877-883

  Onishi, Eijiro ^a   Fujibayashi, Shunsuke ^a   Takemoto, Mitsuru ^a   Neo, Masashi ^a   Maruyama, Takayuki ^b   Kokubo, Tadashi ^c   Nakamura, Takashi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b ONO PHARMACEUTICAL CO   (Japan)

^c CHUBU UNIVERSITY   (Japan)

Author keywords

Animal experiment; Biomaterial; Prostaglandin; Titanium

Indexed keywords

ANIMAL EXPERIMENTS; BONE REMODELING; CEMENTLESS FIXATION DEVICES; PROSTAGLANDIN;

BIOMECHANICS; BONE CEMENT; GENE EXPRESSION; OSTEOBLASTS; SURGERY; TITANIUM ALLOYS;

BIOACTIVITY;

BIOMATERIAL; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2 RECEPTOR AGONIST; TITANIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIOMECHANICS; BONE PLATE; BONE REMODELING; CONTROLLED STUDY; HISTOLOGY; IMPLANT; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RABBIT; TIBIA;

ANIMALS; BONE AND BONES; MALE; MICROSCOPY, ELECTRON, SCANNING; PROSTHESES AND IMPLANTS; RABBITS; RECEPTORS, PROSTAGLANDIN E; STRESS, MECHANICAL; TITANIUM; WEIGHT-BEARING;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 37249079620     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.10.028     Document Type: Article

References (27)

1. D'Antonino J.A., Capello W.N., Manley M.T., and Gessink R. Hydroxyapatite femoral stems for total hip arthroplasty: 10- to 13-years follow-up. Clin Orthop 393 (2001) 101-111
2. Bauer T.W., Geesink R.G.T., Zimmerman R., and McMahon J.T. Hydroxyapatite-coated femoral stems: histological analysis of components retrieved at autopsy. J Bone Jt Surg [Am] 73-A (1991) 1439-1452
3. Hench L.L., and Wilson J. Introduction to bioceramics (1993), World Scientific, Singapore
4. Collier J.P., Surprenant V.A., Mayor M.B., Wrona M., Jensen R.E., and Surprenant H.P. Loss of hydroxyapatite coating on retrieved, total hip components. J Arthroplasty 8 (1993) 389-393
5. Overgaard S., Soballe K., Lind M., and Bunger C. Resorption of hydroxyapatite and fluorapatite coating in man. An experimental study in trabecular bone. J Bone Jt Surg [Br] 79-Br (1997) 654-659
6. KIM H.M., Himeno T., Kawashita M., Lee J.H., Kokubo T., and Nakamura T. Surface potential change in bioactive titanium metal during the process of apatite formation in simulated body fluid. J Biomed Mater Res 67A (2003) 1305-1309
7. Nishiguchi S., Kato H., Fujita H., Oka M., Kim H.M., Kokubo T., et al. Titanium metals form direct bonding to bone after alkali and heat treatments. Biomaterials 22 (2001) 2525-2533
8. Fujibayashi S., Nakamura T., Nishiguchi S., Tamura J., Uchida M., Kim H.M., et al. Bioactive titanium: effect of sodium removal on the bone-bonding ability of bioactive titanium prepared by alkali and heat treatment. J Biomed Mater Res 56 (2001) 562-570
9. Takemoto M., Fujibayashi S., Neo M., Suzuki J., Matsushita T., Kokubo T., et al. Osteoinductive porous titanium implants: effect of sodium removal by dilute HCl treatment. Biomaterials 27 (2006) 2682-2691
10. Li M., Healy D.R., Li Y., Simmons H.A., Crawford D.T., Ke H.Z., et al. Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice. Bone 37 (2005) 46-54
11. Miyaura C., Inada M., Suzawa T., Sugimoto Y., Ushikubi F., Ichikawa A., et al. Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice. J Biol Chem 275-26 (2000) 19819-19823
12. Hagino H., Kuraoka M., Kameyama Y., Okano T., and Teshima R. Effect of a selective agonist for prostaglandin E receptor subtype EP4 (ONO-4819) on the cortical bone response to mechanical loading. Bone 36 (2005) 444-453
13. Simon A.M., Manigrasso M.B., and O'Conor J.P. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 17 (2002) 963-976
14. Narumiya S., Sugimoto Y., and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79 4 (1999) 1193-1226
15. Sugimoto Y., Narumiya S., and Ichikawa A. Distribution and function of prostanoid receptors: studies from knockout mice. Prog Lipid Res 39 4 (2000) 289-314
16. Weinreb M., Machwate M., Shir N., Abramovitz M., Rodan G.A., and Harada S. Expression of the prostaglandin E(2) (PGE(2)) receptor subtype EP(4) and its regulation by PGE(2) in osteoblastic cell lines and adult rat bone tissue. Bone 28 3 (2001) 275-281
17. Shamir D., Keila S., and Weinreb M. A selective EP4 receptor antagonist abrogates the stimulation of osteoblast recruitment from bone marrow stromal cells by prostaglandin E2 in vivo and in vitro. Bone 34 (2004) 157-162
18. Machwate M., Harada S., Leu C.T., Seedor G., Labelle M., Gallant M., et al. Prostaglandin receptor EP (4) mediates the bone anabolic effects of PGE (2). Mol Pharmacol 60 (2001) 36-41
19. Yoshida K., Oida H., Kobayashi T., Maruyama T., Tanaka M., Katayama T., et al. Stimulation of bone formation and prevention of bone loss by prostaglandin EP4 receptor activation. Proc Natl Acad Sci USA 99 (2002) 4580-4585
20. Sasaoka R., Terai H., Toyoda H., Imai Y., Sugama R., and Takaoka K. A prostanoid receptor EP4 agonist enhances ectopic bone formation induced by recombinant human bone morphogenic protein-2. Biochem Biophys Res Commun 318 (2004) 704-709
21. Tanaka M., Sakai A., Uchida S., Tanaka S., Nagashima M., Katayama T., et al. ProstaglandinE2 receptor (EP4) selective agonist (ONO-4819CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local up regulation of bone turnover in mature rats. Bone 34 (2004) 940-948
22. Nakamura T., and Nishiguchi S. Tensile testing of bone-implant interface. Mechanical testing of bone and the bone-implant interface (2000), CRC Press, Boca Raton, FL, USA
23. Hayashi K., Fotovati A., Ali S.A., Oda K., Oida H., and Naito M. Prostaglandin EP4 receptor agonist augments fixation of hydroxyapatite-coated implants in a rat model of osteoporosis. J Bone Jt Surg [Br] 87-B (2005) 1150-1156
24. Masuzawa M., Beppu M., Ishii S., Oyake Y., Aoki H., and Takagi M. Experimental study of bone formation around a titanium rod with β-tricalcium phosphate and prostaglandin E2 receptor agonists. J Orthop Sci 10 (2005) 308-314
25. Namikawa T, Terai H, Hoshino M, Kato M, Toyoda H, Yano K, Nakamura H, Takaoka K. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model. Spine 2005;30(15):1717-22
26. Marui A., Hirose K., Maruyama T., Arai Y., Huang Y., Doi K., et al. Prostaglandin E2 EP4 receptor-selective agonist facilitates sternal healing after harvesting bilateral internal thoracic arteries in diabetic rats. J Thorac Cardiovasc Surg 131 (2006) 587-593
27. Goto J., Araki H., Otomo S., and Aihara H. A comparison of the effect of lipo PGE1 and other related compounds on experimental peripheral arterial occlusive disease in rats. Drugs Exp Clin Res 12 (1986) 917-921